BioCentury
ARTICLE | Finance

Generalists needed

Why new money will be needed to continue biotech’s rally in 3Q17

July 7, 2017 10:43 PM UTC

Following a nearly two-year political overhang on the biotech sector, buysiders believe sentiment once again may be turning positive and starting to catch up with the industry’s positive fundamentals.

As evidence, they point to the continued momentum of biotech indices in the second quarter, which was aided by the perception that drug pricing scrutiny from Washington is easing, coupled with a string of positive clinical catalysts. ...